Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

Recurrent focal myositis developing into a generalised idiopathic inflammatory myopathy with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase autoantibodies.

Lim J, Ten Dam L, Baars PA, Van der Kooi AJ.

BMJ Case Rep. 2019 Nov 2;12(11). pii: e229787. doi: 10.1136/bcr-2019-229787.

PMID:
31678918
2.

Protein array autoantibody profiles to determine diagnostic markers for neuropsychiatric systemic lupus erythematosus.

van der Meulen PM, Barendregt AM, Cuadrado E, Magro-Checa C, Steup-Beekman GM, Schonenberg-Meinema D, Van den Berg JM, Li QZ, Baars PA, Wouters D, Voskuyl AE, Ten Berge IRJM, Huizinga TWJ, Kuijpers TW.

Rheumatology (Oxford). 2017 Aug 1;56(8):1407-1416. doi: 10.1093/rheumatology/kex073.

PMID:
28460084
3.

The best fit: do not discard AL amyloidosis too easily.

Wessel H, Wiersinga WJ, Biemond BJ, Goorhuis A, Baars PA, Krediet CT.

Acta Clin Belg. 2015 Feb;70(1):73-5. doi: 10.1179/2295333714Y.0000000065. Epub 2014 Oct 13. No abstract available.

PMID:
25310720
4.

A reversion of an IL2RG mutation in combined immunodeficiency providing competitive advantage to the majority of CD8+ T cells.

Kuijpers TW, van Leeuwen EM, Barendregt BH, Klarenbeek P, aan de Kerk DJ, Baars PA, Jansen MH, de Vries N, van Lier RA, van der Burg M.

Haematologica. 2013 Jul;98(7):1030-8. doi: 10.3324/haematol.2012.077511. Epub 2013 Feb 12.

5.

A novel mutation in CD132 causes X-CID with defective T-cell activation and impaired humoral reactivity.

Kuijpers TW, Baars PA, Aan de Kerk DJ, Jansen MH, Derks IA, Bredius RG, Sanders EA, van der Burg M, Alders M, van Lier RA.

J Allergy Clin Immunol. 2011 Dec;128(6):1360-1363.e4. doi: 10.1016/j.jaci.2011.07.001. Epub 2011 Aug 9. No abstract available.

PMID:
21831415
6.

Specific expression of GPR56 by human cytotoxic lymphocytes.

Peng YM, van de Garde MD, Cheng KF, Baars PA, Remmerswaal EB, van Lier RA, Mackay CR, Lin HH, Hamann J.

J Leukoc Biol. 2011 Oct;90(4):735-40. doi: 10.1189/jlb.0211092. Epub 2011 Jul 1.

PMID:
21724806
7.

Common variable immunodeficiency and hemophagocytic features associated with a FAS gene mutation.

Kuijpers TW, Baars PA, aan de Kerk DJ, Jansen MH, Dors N, van Lier RA, Pals ST.

J Allergy Clin Immunol. 2011 Jun;127(6):1411-4.e2. doi: 10.1016/j.jaci.2011.01.046. Epub 2011 Mar 29. No abstract available.

PMID:
21450335
8.

CD20 deficiency in humans results in impaired T cell-independent antibody responses.

Kuijpers TW, Bende RJ, Baars PA, Grummels A, Derks IA, Dolman KM, Beaumont T, Tedder TF, van Noesel CJ, Eldering E, van Lier RA.

J Clin Invest. 2010 Jan;120(1):214-22. doi: 10.1172/JCI40231. Epub 2009 Dec 21.

9.

Human NK cells can control CMV infection in the absence of T cells.

Kuijpers TW, Baars PA, Dantin C, van den Burg M, van Lier RA, Roosnek E.

Blood. 2008 Aug 1;112(3):914-5. doi: 10.1182/blood-2008-05-157354. No abstract available.

PMID:
18650467
10.

CD27 defines phenotypically and functionally different human NK cell subsets.

Vossen MT, Matmati M, Hertoghs KM, Baars PA, Gent MR, Leclercq G, Hamann J, Kuijpers TW, van Lier RA.

J Immunol. 2008 Mar 15;180(6):3739-45.

11.

Properties of murine (CD8+)CD27- T cells.

Baars PA, Sierro S, Arens R, Tesselaar K, Hooibrink B, Klenerman P, van Lier RA.

Eur J Immunol. 2005 Nov;35(11):3131-41.

12.

Cutting edge: CD95 maintains effector T cell homeostasis in chronic immune activation.

Arens R, Baars PA, Jak M, Tesselaar K, van der Valk M, van Oers MH, van Lier RA.

J Immunol. 2005 May 15;174(10):5915-20.

13.

Absence of circulating natural killer and primed CD8+ cells in life-threatening varicella.

Vossen MT, Biezeveld MH, de Jong MD, Gent MR, Baars PA, von Rosenstiel IA, van Lier RA, Kuijpers TW.

J Infect Dis. 2005 Jan 15;191(2):198-206. Epub 2004 Dec 15.

PMID:
15609229
14.

Expression of adhesion molecules on peripheral lymphocytes predicts future lesion development in MS.

Eikelenboom MJ, Killestein J, Izeboud T, Kalkers NF, Baars PA, van Lier RA, Barkhof F, Uitdehaag BM, Polman CH.

J Neuroimmunol. 2005 Jan;158(1-2):222-30.

PMID:
15589057
15.

Spontaneous outgrowth of EBV-transformed B-cells reflects EBV-specific immunity in vivo; a useful tool in the follow-up of EBV-driven immunoproliferative disorders in allograft recipients.

Vossen MT, Gent MR, Davin JC, Baars PA, Wertheim-van Dillen PM, Weel JF, Roos MT, van Baarle D, Groothoff J, van Lier RA, Kuijpers TW.

Transpl Int. 2004 Feb;17(2):89-96. Epub 2003 Dec 2.

16.

Frequencies of circulating cytolytic, CD45RA+CD27-, CD8+ T lymphocytes depend on infection with CMV.

Kuijpers TW, Vossen MT, Gent MR, Davin JC, Roos MT, Wertheim-van Dillen PM, Weel JF, Baars PA, van Lier RA.

J Immunol. 2003 Apr 15;170(8):4342-8.

17.

Lethal T cell immunodeficiency induced by chronic costimulation via CD27-CD70 interactions.

Tesselaar K, Arens R, van Schijndel GM, Baars PA, van der Valk MA, Borst J, van Oers MH, van Lier RA.

Nat Immunol. 2003 Jan;4(1):49-54. Epub 2002 Dec 9. Erratum in: Nat Immunol. 2003 Mar;4(3):295.

PMID:
12469117
18.

Baseline T cell reactivity in multiple sclerosis is correlated to efficacy of interferon-beta.

Killestein J, Hintzen RQ, Uitdehaag BM, Baars PA, Roos MT, van Lier RA, Polman CH.

J Neuroimmunol. 2002 Dec;133(1-2):217-24.

PMID:
12446026
19.

Proliferation requirements of cytomegalovirus-specific, effector-type human CD8+ T cells.

van Leeuwen EM, Gamadia LE, Baars PA, Remmerswaal EB, ten Berge IJ, van Lier RA.

J Immunol. 2002 Nov 15;169(10):5838-43.

20.

Constitutive CD27/CD70 interaction induces expansion of effector-type T cells and results in IFNgamma-mediated B cell depletion.

Arens R, Tesselaar K, Baars PA, van Schijndel GM, Hendriks J, Pals ST, Krimpenfort P, Borst J, van Oers MH, van Lier RA.

Immunity. 2001 Nov;15(5):801-12.

21.

Differentiation of cytomegalovirus-specific CD8(+) T cells in healthy and immunosuppressed virus carriers.

Gamadia LE, Rentenaar RJ, Baars PA, Remmerswaal EB, Surachno S, Weel JF, Toebes M, Schumacher TN, ten Berge IJ, van Lier RA.

Blood. 2001 Aug 1;98(3):754-61.

PMID:
11468176
22.

Cytolytic mechanisms and expression of activation-regulating receptors on effector-type CD8+CD45RA+CD27- human T cells.

Baars PA, Ribeiro Do Couto LM, Leusen JH, Hooibrink B, Kuijpers TW, Lens SM, van Lier RA.

J Immunol. 2000 Aug 15;165(4):1910-7.

23.

Assessing the replicative history of human T cells.

Van Lier RA, Baars PA.

Mutat Res. 1999 Dec 17;431(2):177-80. Review.

PMID:
10635984
24.

Evidence that human CD8+CD45RA+CD27- cells are induced by antigen and evolve through extensive rounds of division.

Hamann D, Kostense S, Wolthers KC, Otto SA, Baars PA, Miedema F, van Lier RA.

Int Immunol. 1999 Jul;11(7):1027-33.

PMID:
10383934
25.

Phenotypic and functional separation of memory and effector human CD8+ T cells.

Hamann D, Baars PA, Rep MH, Hooibrink B, Kerkhof-Garde SR, Klein MR, van Lier RA.

J Exp Med. 1997 Nov 3;186(9):1407-18.

26.

Antigen-presenting cell-derived signals determine expression levels of CD70 on primed T cells.

Lens SM, Baars PA, Hooibrink B, van Oers MH, van Lier RA.

Immunology. 1997 Jan;90(1):38-45.

27.
28.
29.

Glucosidase trimming inhibitors preferentially perturb T cell activation induced by CD2 mAb.

van Kemenade FJ, Rotteveel FT, van den Broek LA, Baars PA, van Lier RA, Miedema F.

J Leukoc Biol. 1994 Aug;56(2):159-65.

PMID:
7915296
30.

Elevated levels of a soluble form of the T cell activation antigen CD27 in cerebrospinal fluid of multiple sclerosis patients.

Hintzen RQ, van Lier RA, Kuijpers KC, Baars PA, Schaasberg W, Lucas CJ, Polman CH.

J Neuroimmunol. 1991 Dec;35(1-3):211-7.

PMID:
1659587

Supplemental Content

Loading ...
Support Center